• 1768 Citations
  • 18 h-Index
1986 …2018
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Sidney A Scudder is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 16 Similar Profiles
Ovarian Neoplasms Medicine & Life Sciences
Drug Therapy Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Carboplatin Medicine & Life Sciences
Platinum Medicine & Life Sciences
Cyclophosphamide Medicine & Life Sciences
Disease-Free Survival Medicine & Life Sciences
Therapeutics Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1986 2018

  • 1768 Citations
  • 18 h-Index
  • 32 Article
1 Citation (Scopus)

Clinical utility of a blood-based EGFR mutation test in patients receiving first-line erlotinib therapy in the ENSURE, FASTACT-2, and ASPIRATION studies

on behalf of the ENSURE FASTACT-2 and ASPIRATION Investigators, Dec 1 2018, In : Lung Cancer. 126, p. 1-8 8 p.

Research output: Contribution to journalArticle

Epidermal Growth Factor Receptor
Tumor Burden
5 Citations (Scopus)

Detection of EGFR Variants in Plasma: A Multilaboratory Comparison of a Real-Time PCR EGFR Mutation Test in Europe

Keppens, C., Palma, J. F., Das, P. M., Scudder, S. A., Wen, W., Normanno, N., van Krieken, J. H., Sacco, A., Fenizia, F., Gonzalez de Castro, D., Hönigschnabl, S., Kern, I., Lopez-Rios, F., Lozano, M. D., Marchetti, A., Halfon, P., Schuuring, E., Setinek, U., Sorensen, B., Taniere, P. & 3 others, Tiemann, M., Vosmikova, H. & Dequeker, E. M. C., Jul 1 2018, In : Journal of Molecular Diagnostics. 20, 4, p. 483-494 12 p.

Research output: Contribution to journalArticle

Real-Time Polymerase Chain Reaction
Non-Small Cell Lung Carcinoma

The clinical and economic impact of inaccurate EGFR mutation tests in the treatment of metastatic non-small cell lung cancer

Cheng, M. M., Palma, J. F., Scudder, S. A., Poulios, N. & Liesenfeld, O., Sep 1 2017, In : Journal of Personalized Medicine. 7, 3, 5.

Research output: Contribution to journalArticle

Epidermal Growth Factor Receptor
Non-Small Cell Lung Carcinoma
United States Food and Drug Administration
14 Citations (Scopus)

A phase 1b study of trebananib in combination with pegylated liposomal doxorubicin or topotecan in women with recurrent platinum-resistant or partially platinum-sensitive ovarian cancer

Vergote, I., Schilder, R. J., Pippitt, C. H., Wong, S., Gordon, A. N., Scudder, S. A., Kridelka, F., Dirix, L., Leach, J. W., Ananda, S., Nanayakkara, N., Melara, R., Bass, M. B., Litten, J., Adewoye, H. & Wenham, R. M., Oct 1 2014, In : Gynecologic Oncology. 135, 1, p. 25-33 9 p.

Research output: Contribution to journalArticle

Ovarian Neoplasms
Pulmonary Embolism
Disease Progression
40 Citations (Scopus)
Appointments and Schedules
Non-Small Cell Lung Carcinoma
Epidermal Growth Factor Receptor